Whether you are looking for FAQ’s or product documents we hope you find what you need here but feel free to reach out if you dont.
Sentinel Lymph Node Biopsy (SLNB) has been widely accepted as the replacement for axillary lymph node dissection as the staging procedure for early node-negative breast cancer.
Traditionally SLNB involves injecting radioactive drugs which are dependent on nuclear medicine availability and blue dyes that can put a patient at risk for anaphylaxis and skin necrosis.
Magnetic SLNB uses a single tracer that offers the freedom to be injected in the operating room or up to seven days beforehand to improve scheduling and the patient experience.
We offer a wide variety of breast biopsy markers for stereotactic procedures that are compatible with both Mammotome breast biopsy devices as well as other breast biopsy devices available on the market today.